-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Gossamer Bio, Lowers Price Target to $32

Benzinga·11/11/2026 14:14:30
Listen to the news
Wedbush analyst Laura Chico maintains Gossamer Bio (NASDAQ:GOSS) with a Neutral and lowers the price target from $80 to $32.